Pharma & Healthcare
Global Celecoxib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 437030
- Pages: 78
- Figures: 78
- Views: 2
The global Celecoxib market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
By Type: (Dominant Segment vs High-Margin Innovation)
50mg
100mg
200mg
400mg
By Application: (Core Demand Driver vs Emerging Opportunity)
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Pfizer Inc in Europe)
- Emerging Product Trends: 50mg adoption vs. 100mg premiumization
- Demand-Side Dynamics: Rheumatoid arthritis growth in China vs. osteoarthritis potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Celecoxib market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 100mg in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., osteoarthritis in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., 50mg dominance in Europe vs. 100mg demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Market Segmentation
By Company:
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
By Type: (Dominant Segment vs High-Margin Innovation)
50mg
100mg
200mg
400mg
By Application: (Core Demand Driver vs Emerging Opportunity)
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Pfizer Inc in Europe)
- Emerging Product Trends: 50mg adoption vs. 100mg premiumization
- Demand-Side Dynamics: Rheumatoid arthritis growth in China vs. osteoarthritis potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Celecoxib market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 100mg in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., osteoarthritis in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., 50mg dominance in Europe vs. 100mg demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Celecoxib Product Scope
1.2 Celecoxib by Type
1.2.1 Global Celecoxib Sales by Type (2020 & 2024 & 2031)
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Celecoxib by Application
1.3.1 Global Celecoxib Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Rheumatoid arthritis
1.3.3 osteoarthritis
1.3.4 Acute pain
1.3.5 Musculoskeletal pain
1.3.6 Other diseases
1.4 Global Celecoxib Market Estimates and Forecasts (2020-2031)
1.4.1 Global Celecoxib Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Celecoxib Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Celecoxib Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Celecoxib Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Celecoxib Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Celecoxib Sales Market Share by Region (2020-2025)
2.2.2 Global Celecoxib Revenue Market Share by Region (2020-2025)
2.3 Global Celecoxib Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Celecoxib Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Celecoxib Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Celecoxib Market Size and Prospective (2020-2031)
2.4.2 Europe Celecoxib Market Size and Prospective (2020-2031)
2.4.3 China Celecoxib Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Celecoxib Historic Market Review by Type (2020-2025)
3.1.1 Global Celecoxib Sales by Type (2020-2025)
3.1.2 Global Celecoxib Revenue by Type (2020-2025)
3.1.3 Global Celecoxib Price by Type (2020-2025)
3.2 Global Celecoxib Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Celecoxib Sales Forecast by Type (2026-2031)
3.2.2 Global Celecoxib Revenue Forecast by Type (2026-2031)
3.2.3 Global Celecoxib Price Forecast by Type (2026-2031)
3.3 Different Types Celecoxib Representative Players
4 Global Market Size by Application
4.1 Global Celecoxib Historic Market Review by Application (2020-2025)
4.1.1 Global Celecoxib Sales by Application (2020-2025)
4.1.2 Global Celecoxib Revenue by Application (2020-2025)
4.1.3 Global Celecoxib Price by Application (2020-2025)
4.2 Global Celecoxib Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Celecoxib Sales Forecast by Application (2026-2031)
4.2.2 Global Celecoxib Revenue Forecast by Application (2026-2031)
4.2.3 Global Celecoxib Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Celecoxib Application
5 Competition Landscape by Players
5.1 Global Celecoxib Sales by Players (2020-2025)
5.2 Global Top Celecoxib Players by Revenue (2020-2025)
5.3 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2024)
5.4 Global Celecoxib Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Celecoxib, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Celecoxib, Product Type & Application
5.7 Global Key Manufacturers of Celecoxib, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Celecoxib Sales by Company
6.1.1.1 North America Celecoxib Sales by Company (2020-2025)
6.1.1.2 North America Celecoxib Revenue by Company (2020-2025)
6.1.2 North America Celecoxib Sales Breakdown by Type (2020-2025)
6.1.3 North America Celecoxib Sales Breakdown by Application (2020-2025)
6.1.4 North America Celecoxib Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Celecoxib Sales by Company
6.2.1.1 Europe Celecoxib Sales by Company (2020-2025)
6.2.1.2 Europe Celecoxib Revenue by Company (2020-2025)
6.2.2 Europe Celecoxib Sales Breakdown by Type (2020-2025)
6.2.3 Europe Celecoxib Sales Breakdown by Application (2020-2025)
6.2.4 Europe Celecoxib Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Celecoxib Sales by Company
6.3.1.1 China Celecoxib Sales by Company (2020-2025)
6.3.1.2 China Celecoxib Revenue by Company (2020-2025)
6.3.2 China Celecoxib Sales Breakdown by Type (2020-2025)
6.3.3 China Celecoxib Sales Breakdown by Application (2020-2025)
6.3.4 China Celecoxib Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Information
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Pfizer Inc Celecoxib Products Offered
7.1.5 Pfizer Inc Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Business Overview
7.2.3 Teva Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Teva Celecoxib Products Offered
7.2.5 Teva Recent Development
7.3 Mylan
7.3.1 Mylan Company Information
7.3.2 Mylan Business Overview
7.3.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Mylan Celecoxib Products Offered
7.3.5 Mylan Recent Development
7.4 Apotex
7.4.1 Apotex Company Information
7.4.2 Apotex Business Overview
7.4.3 Apotex Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Apotex Celecoxib Products Offered
7.4.5 Apotex Recent Development
7.5 Lupin
7.5.1 Lupin Company Information
7.5.2 Lupin Business Overview
7.5.3 Lupin Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Lupin Celecoxib Products Offered
7.5.5 Lupin Recent Development
7.6 Hengrui Medicine
7.6.1 Hengrui Medicine Company Information
7.6.2 Hengrui Medicine Business Overview
7.6.3 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Hengrui Medicine Celecoxib Products Offered
7.6.5 Hengrui Medicine Recent Development
8 Celecoxib Manufacturing Cost Analysis
8.1 Celecoxib Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Celecoxib
8.4 Celecoxib Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Celecoxib Distributors List
9.3 Celecoxib Customers
10 Celecoxib Market Dynamics
10.1 Celecoxib Industry Trends
10.2 Celecoxib Market Drivers
10.3 Celecoxib Market Challenges
10.4 Celecoxib Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Celecoxib Product Scope
1.2 Celecoxib by Type
1.2.1 Global Celecoxib Sales by Type (2020 & 2024 & 2031)
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Celecoxib by Application
1.3.1 Global Celecoxib Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Rheumatoid arthritis
1.3.3 osteoarthritis
1.3.4 Acute pain
1.3.5 Musculoskeletal pain
1.3.6 Other diseases
1.4 Global Celecoxib Market Estimates and Forecasts (2020-2031)
1.4.1 Global Celecoxib Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Celecoxib Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Celecoxib Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Celecoxib Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Celecoxib Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Celecoxib Sales Market Share by Region (2020-2025)
2.2.2 Global Celecoxib Revenue Market Share by Region (2020-2025)
2.3 Global Celecoxib Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Celecoxib Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Celecoxib Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Celecoxib Market Size and Prospective (2020-2031)
2.4.2 Europe Celecoxib Market Size and Prospective (2020-2031)
2.4.3 China Celecoxib Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Celecoxib Historic Market Review by Type (2020-2025)
3.1.1 Global Celecoxib Sales by Type (2020-2025)
3.1.2 Global Celecoxib Revenue by Type (2020-2025)
3.1.3 Global Celecoxib Price by Type (2020-2025)
3.2 Global Celecoxib Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Celecoxib Sales Forecast by Type (2026-2031)
3.2.2 Global Celecoxib Revenue Forecast by Type (2026-2031)
3.2.3 Global Celecoxib Price Forecast by Type (2026-2031)
3.3 Different Types Celecoxib Representative Players
4 Global Market Size by Application
4.1 Global Celecoxib Historic Market Review by Application (2020-2025)
4.1.1 Global Celecoxib Sales by Application (2020-2025)
4.1.2 Global Celecoxib Revenue by Application (2020-2025)
4.1.3 Global Celecoxib Price by Application (2020-2025)
4.2 Global Celecoxib Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Celecoxib Sales Forecast by Application (2026-2031)
4.2.2 Global Celecoxib Revenue Forecast by Application (2026-2031)
4.2.3 Global Celecoxib Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Celecoxib Application
5 Competition Landscape by Players
5.1 Global Celecoxib Sales by Players (2020-2025)
5.2 Global Top Celecoxib Players by Revenue (2020-2025)
5.3 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2024)
5.4 Global Celecoxib Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Celecoxib, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Celecoxib, Product Type & Application
5.7 Global Key Manufacturers of Celecoxib, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Celecoxib Sales by Company
6.1.1.1 North America Celecoxib Sales by Company (2020-2025)
6.1.1.2 North America Celecoxib Revenue by Company (2020-2025)
6.1.2 North America Celecoxib Sales Breakdown by Type (2020-2025)
6.1.3 North America Celecoxib Sales Breakdown by Application (2020-2025)
6.1.4 North America Celecoxib Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Celecoxib Sales by Company
6.2.1.1 Europe Celecoxib Sales by Company (2020-2025)
6.2.1.2 Europe Celecoxib Revenue by Company (2020-2025)
6.2.2 Europe Celecoxib Sales Breakdown by Type (2020-2025)
6.2.3 Europe Celecoxib Sales Breakdown by Application (2020-2025)
6.2.4 Europe Celecoxib Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Celecoxib Sales by Company
6.3.1.1 China Celecoxib Sales by Company (2020-2025)
6.3.1.2 China Celecoxib Revenue by Company (2020-2025)
6.3.2 China Celecoxib Sales Breakdown by Type (2020-2025)
6.3.3 China Celecoxib Sales Breakdown by Application (2020-2025)
6.3.4 China Celecoxib Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Information
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Pfizer Inc Celecoxib Products Offered
7.1.5 Pfizer Inc Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Business Overview
7.2.3 Teva Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Teva Celecoxib Products Offered
7.2.5 Teva Recent Development
7.3 Mylan
7.3.1 Mylan Company Information
7.3.2 Mylan Business Overview
7.3.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Mylan Celecoxib Products Offered
7.3.5 Mylan Recent Development
7.4 Apotex
7.4.1 Apotex Company Information
7.4.2 Apotex Business Overview
7.4.3 Apotex Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Apotex Celecoxib Products Offered
7.4.5 Apotex Recent Development
7.5 Lupin
7.5.1 Lupin Company Information
7.5.2 Lupin Business Overview
7.5.3 Lupin Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Lupin Celecoxib Products Offered
7.5.5 Lupin Recent Development
7.6 Hengrui Medicine
7.6.1 Hengrui Medicine Company Information
7.6.2 Hengrui Medicine Business Overview
7.6.3 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Hengrui Medicine Celecoxib Products Offered
7.6.5 Hengrui Medicine Recent Development
8 Celecoxib Manufacturing Cost Analysis
8.1 Celecoxib Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Celecoxib
8.4 Celecoxib Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Celecoxib Distributors List
9.3 Celecoxib Customers
10 Celecoxib Market Dynamics
10.1 Celecoxib Industry Trends
10.2 Celecoxib Market Drivers
10.3 Celecoxib Market Challenges
10.4 Celecoxib Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Celecoxib Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Celecoxib Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Celecoxib Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Celecoxib Sales (K Units) by Region (2020-2025)
Table 5. Global Celecoxib Sales Market Share by Region (2020-2025)
Table 6. Global Celecoxib Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Celecoxib Revenue Share by Region (2020-2025)
Table 8. Global Celecoxib Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Celecoxib Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Celecoxib Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Celecoxib Revenue Share Forecast by Region (2026-2031)
Table 12. Global Celecoxib Sales by Type (K Units) & (2020-2025)
Table 13. Global Celecoxib Sales Share by Type (2020-2025)
Table 14. Global Celecoxib Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Celecoxib Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Celecoxib Sales by Type (K Units) & (2026-2031)
Table 17. Global Celecoxib Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Celecoxib Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Celecoxib Sales by Application (K Units) & (2020-2025)
Table 21. Global Celecoxib Sales Share by Application (2020-2025)
Table 22. Global Celecoxib Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Celecoxib Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Celecoxib Sales by Application (K Units) & (2026-2031)
Table 25. Global Celecoxib Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Celecoxib Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Celecoxib Application
Table 28. Global Celecoxib Sales by Company (K Units) & (2020-2025)
Table 29. Global Celecoxib Sales Share by Company (2020-2025)
Table 30. Global Celecoxib Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Celecoxib Revenue Share by Company (2020-2025)
Table 32. Global Celecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2024)
Table 33. Global Market Celecoxib Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Celecoxib, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Celecoxib, Product Type & Application
Table 36. Global Key Manufacturers of Celecoxib, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Celecoxib Sales by Company (2020-2025) & (K Units)
Table 39. North America Celecoxib Sales Market Share by Company (2020-2025)
Table 40. North America Celecoxib Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Celecoxib Revenue Market Share by Company (2020-2025)
Table 42. North America Celecoxib Sales by Type (2020-2025) & (K Units)
Table 43. North America Celecoxib Sales Market Share by Type (2020-2025)
Table 44. North America Celecoxib Sales by Application (2020-2025) & (K Units)
Table 45. North America Celecoxib Sales Market Share by Application (2020-2025)
Table 46. Europe Celecoxib Sales by Company (2020-2025) & (K Units)
Table 47. Europe Celecoxib Sales Market Share by Company (2020-2025)
Table 48. Europe Celecoxib Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Celecoxib Revenue Market Share by Company (2020-2025)
Table 50. Europe Celecoxib Sales by Type (2020-2025) & (K Units)
Table 51. Europe Celecoxib Sales Market Share by Type (2020-2025)
Table 52. Europe Celecoxib Sales by Application (2020-2025) & (K Units)
Table 53. Europe Celecoxib Sales Market Share by Application (2020-2025)
Table 54. China Celecoxib Sales by Company (2020-2025) & (K Units)
Table 55. China Celecoxib Sales Market Share by Company (2020-2025)
Table 56. China Celecoxib Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Celecoxib Revenue Market Share by Company (2020-2025)
Table 58. China Celecoxib Sales by Type (2020-2025) & (K Units)
Table 59. China Celecoxib Sales Market Share by Type (2020-2025)
Table 60. China Celecoxib Sales by Application (2020-2025) & (K Units)
Table 61. China Celecoxib Sales Market Share by Application (2020-2025)
Table 62. Pfizer Inc Company Information
Table 63. Pfizer Inc Description and Business Overview
Table 64. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Pfizer Inc Celecoxib Product
Table 66. Pfizer Inc Recent Development
Table 67. Teva Company Information
Table 68. Teva Description and Business Overview
Table 69. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Teva Celecoxib Product
Table 71. Teva Recent Development
Table 72. Mylan Company Information
Table 73. Mylan Description and Business Overview
Table 74. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Mylan Celecoxib Product
Table 76. Mylan Recent Development
Table 77. Apotex Company Information
Table 78. Apotex Description and Business Overview
Table 79. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Apotex Celecoxib Product
Table 81. Apotex Recent Development
Table 82. Lupin Company Information
Table 83. Lupin Description and Business Overview
Table 84. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Lupin Celecoxib Product
Table 86. Lupin Recent Development
Table 87. Hengrui Medicine Company Information
Table 88. Hengrui Medicine Description and Business Overview
Table 89. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Hengrui Medicine Celecoxib Product
Table 91. Hengrui Medicine Recent Development
Table 92. Production Base and Market Concentration Rate of Raw Material
Table 93. Key Suppliers of Raw Materials
Table 94. Celecoxib Distributors List
Table 95. Celecoxib Customers List
Table 96. Celecoxib Market Trends
Table 97. Celecoxib Market Drivers
Table 98. Celecoxib Market Challenges
Table 99. Celecoxib Market Restraints
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Celecoxib Product Picture
Figure 2. Global Celecoxib Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Celecoxib Sales Market Share by Type in 2024 & 2031
Figure 4. 50mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. 200mg Product Picture
Figure 7. 400mg Product Picture
Figure 8. Global Celecoxib Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Celecoxib Sales Market Share by Application in 2024 & 2031
Figure 10. Rheumatoid arthritis Examples
Figure 11. osteoarthritis Examples
Figure 12. Acute pain Examples
Figure 13. Musculoskeletal pain Examples
Figure 14. Other diseases Examples
Figure 15. Global Celecoxib Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Celecoxib Sales Growth Rate (2020-2031) & (US$ Million)
Figure 17. Global Celecoxib Sales (K Units) Growth Rate (2020-2031)
Figure 18. Global Celecoxib Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 19. Celecoxib Report Years Considered
Figure 20. Global Market Celecoxib Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 21. Global Celecoxib Revenue Market Share by Region: 2020 VS 2024
Figure 22. North America Celecoxib Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. North America Celecoxib Sales (K Units) Growth Rate (2020-2031)
Figure 24. Europe Celecoxib Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Europe Celecoxib Sales (K Units) Growth Rate (2020-2031)
Figure 26. China Celecoxib Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. China Celecoxib Sales (K Units) Growth Rate (2020-2031)
Figure 28. Global Celecoxib Revenue Share by Type (2020-2025)
Figure 29. Global Celecoxib Sales Share by Type (2026-2031)
Figure 30. Global Celecoxib Revenue Share by Type (2026-2031)
Figure 31. Global Celecoxib Revenue Share by Application (2020-2025)
Figure 32. Global Celecoxib Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Celecoxib Sales Share by Application (2026-2031)
Figure 34. Global Celecoxib Revenue Share by Application (2026-2031)
Figure 35. Global Celecoxib Sales Share by Company (2024)
Figure 36. Global Celecoxib Revenue Share by Company (2024)
Figure 37. Global 5 Largest Celecoxib Players Market Share by Revenue in Celecoxib: 2020 & 2024
Figure 38. Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Celecoxib
Figure 40. Manufacturing Process Analysis of Celecoxib
Figure 41. Celecoxib Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Table 1. Global Celecoxib Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Celecoxib Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Celecoxib Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Celecoxib Sales (K Units) by Region (2020-2025)
Table 5. Global Celecoxib Sales Market Share by Region (2020-2025)
Table 6. Global Celecoxib Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Celecoxib Revenue Share by Region (2020-2025)
Table 8. Global Celecoxib Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Celecoxib Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Celecoxib Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Celecoxib Revenue Share Forecast by Region (2026-2031)
Table 12. Global Celecoxib Sales by Type (K Units) & (2020-2025)
Table 13. Global Celecoxib Sales Share by Type (2020-2025)
Table 14. Global Celecoxib Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Celecoxib Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Celecoxib Sales by Type (K Units) & (2026-2031)
Table 17. Global Celecoxib Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Celecoxib Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Celecoxib Sales by Application (K Units) & (2020-2025)
Table 21. Global Celecoxib Sales Share by Application (2020-2025)
Table 22. Global Celecoxib Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Celecoxib Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Celecoxib Sales by Application (K Units) & (2026-2031)
Table 25. Global Celecoxib Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Celecoxib Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Celecoxib Application
Table 28. Global Celecoxib Sales by Company (K Units) & (2020-2025)
Table 29. Global Celecoxib Sales Share by Company (2020-2025)
Table 30. Global Celecoxib Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Celecoxib Revenue Share by Company (2020-2025)
Table 32. Global Celecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2024)
Table 33. Global Market Celecoxib Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Celecoxib, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Celecoxib, Product Type & Application
Table 36. Global Key Manufacturers of Celecoxib, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Celecoxib Sales by Company (2020-2025) & (K Units)
Table 39. North America Celecoxib Sales Market Share by Company (2020-2025)
Table 40. North America Celecoxib Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Celecoxib Revenue Market Share by Company (2020-2025)
Table 42. North America Celecoxib Sales by Type (2020-2025) & (K Units)
Table 43. North America Celecoxib Sales Market Share by Type (2020-2025)
Table 44. North America Celecoxib Sales by Application (2020-2025) & (K Units)
Table 45. North America Celecoxib Sales Market Share by Application (2020-2025)
Table 46. Europe Celecoxib Sales by Company (2020-2025) & (K Units)
Table 47. Europe Celecoxib Sales Market Share by Company (2020-2025)
Table 48. Europe Celecoxib Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Celecoxib Revenue Market Share by Company (2020-2025)
Table 50. Europe Celecoxib Sales by Type (2020-2025) & (K Units)
Table 51. Europe Celecoxib Sales Market Share by Type (2020-2025)
Table 52. Europe Celecoxib Sales by Application (2020-2025) & (K Units)
Table 53. Europe Celecoxib Sales Market Share by Application (2020-2025)
Table 54. China Celecoxib Sales by Company (2020-2025) & (K Units)
Table 55. China Celecoxib Sales Market Share by Company (2020-2025)
Table 56. China Celecoxib Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Celecoxib Revenue Market Share by Company (2020-2025)
Table 58. China Celecoxib Sales by Type (2020-2025) & (K Units)
Table 59. China Celecoxib Sales Market Share by Type (2020-2025)
Table 60. China Celecoxib Sales by Application (2020-2025) & (K Units)
Table 61. China Celecoxib Sales Market Share by Application (2020-2025)
Table 62. Pfizer Inc Company Information
Table 63. Pfizer Inc Description and Business Overview
Table 64. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Pfizer Inc Celecoxib Product
Table 66. Pfizer Inc Recent Development
Table 67. Teva Company Information
Table 68. Teva Description and Business Overview
Table 69. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Teva Celecoxib Product
Table 71. Teva Recent Development
Table 72. Mylan Company Information
Table 73. Mylan Description and Business Overview
Table 74. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Mylan Celecoxib Product
Table 76. Mylan Recent Development
Table 77. Apotex Company Information
Table 78. Apotex Description and Business Overview
Table 79. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Apotex Celecoxib Product
Table 81. Apotex Recent Development
Table 82. Lupin Company Information
Table 83. Lupin Description and Business Overview
Table 84. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Lupin Celecoxib Product
Table 86. Lupin Recent Development
Table 87. Hengrui Medicine Company Information
Table 88. Hengrui Medicine Description and Business Overview
Table 89. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Hengrui Medicine Celecoxib Product
Table 91. Hengrui Medicine Recent Development
Table 92. Production Base and Market Concentration Rate of Raw Material
Table 93. Key Suppliers of Raw Materials
Table 94. Celecoxib Distributors List
Table 95. Celecoxib Customers List
Table 96. Celecoxib Market Trends
Table 97. Celecoxib Market Drivers
Table 98. Celecoxib Market Challenges
Table 99. Celecoxib Market Restraints
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Celecoxib Product Picture
Figure 2. Global Celecoxib Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Celecoxib Sales Market Share by Type in 2024 & 2031
Figure 4. 50mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. 200mg Product Picture
Figure 7. 400mg Product Picture
Figure 8. Global Celecoxib Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Celecoxib Sales Market Share by Application in 2024 & 2031
Figure 10. Rheumatoid arthritis Examples
Figure 11. osteoarthritis Examples
Figure 12. Acute pain Examples
Figure 13. Musculoskeletal pain Examples
Figure 14. Other diseases Examples
Figure 15. Global Celecoxib Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Celecoxib Sales Growth Rate (2020-2031) & (US$ Million)
Figure 17. Global Celecoxib Sales (K Units) Growth Rate (2020-2031)
Figure 18. Global Celecoxib Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 19. Celecoxib Report Years Considered
Figure 20. Global Market Celecoxib Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 21. Global Celecoxib Revenue Market Share by Region: 2020 VS 2024
Figure 22. North America Celecoxib Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. North America Celecoxib Sales (K Units) Growth Rate (2020-2031)
Figure 24. Europe Celecoxib Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Europe Celecoxib Sales (K Units) Growth Rate (2020-2031)
Figure 26. China Celecoxib Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. China Celecoxib Sales (K Units) Growth Rate (2020-2031)
Figure 28. Global Celecoxib Revenue Share by Type (2020-2025)
Figure 29. Global Celecoxib Sales Share by Type (2026-2031)
Figure 30. Global Celecoxib Revenue Share by Type (2026-2031)
Figure 31. Global Celecoxib Revenue Share by Application (2020-2025)
Figure 32. Global Celecoxib Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Celecoxib Sales Share by Application (2026-2031)
Figure 34. Global Celecoxib Revenue Share by Application (2026-2031)
Figure 35. Global Celecoxib Sales Share by Company (2024)
Figure 36. Global Celecoxib Revenue Share by Company (2024)
Figure 37. Global 5 Largest Celecoxib Players Market Share by Revenue in Celecoxib: 2020 & 2024
Figure 38. Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Celecoxib
Figure 40. Manufacturing Process Analysis of Celecoxib
Figure 41. Celecoxib Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232